https://www.ft.com/content/a5a94445-9185-4c26-be6a-ae3303838d81
6 replies (most recent on top)
Only thing worse than the total non compliant Inspire Quality, would be factory blueprint.
The only way for long term success, that doesn't include extracting value through stock price, is a change in leadership and perspective.
BD Leaderships' current understanding of 'change' is equivalent to putting a wrap on a rotting hooptie. For example - Inspire Quality is just a wrapper on top of existing bad and inefficient processes to make them sound great and compliant.
does antitrust really matter with the current US administration? who is going to buck it?
No new information in this article. Just speculations. Both danaher and Thermo Fisher have a flow business so it'll not pass anti trust.
I hope the whole BD is acquired by a company which has credible leaders with qualifications unlike as**les that we have. Most problems would be resolved once we have good top leadership.
For those who are getting a paywall on FT, here is a Reuters article: https://www.reuters.com/business/healthcare-pharmaceuticals/becton-di-kinson-talks-divest-life-sciences-unit-ft-reports-2025-04-01/